By correlating ITSS with a comprehensive panel of molecular alterations (including IDH mutation, 1p/19q co-deletion, and CDKN2A/B homozygous deletion), our findings demonstrate the relevance of semiquantitative ITSS grading in the current era of molecularly driven glioma characterization. Here, CDKN2A is linked to central nervous system cancer.